How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for

Microdermabrasion

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

or vitamin A supplements greater than 10,000 units/day within 6 months prior to Baseline Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 8 weeks Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03073486 Sponsors

2017 Clinical Trials

42. Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

requiring topical ocular treatment within the last 1 month, r) Ocular laser within the last 3 months, s) Aesthetic, cosmetic or dermatological treatment in the treatment area (face), including the use of skin tone lightning products, within the last 3 months, t) Use of facial scrubs, depilatory creams, waxing and/or bleaching within the last 2 weeks prior to screening, u) Microdermabrasion and/or laser hair removal within the last 4 weeks prior to screening, v) Medical history of Herpes Simplex (Cold

2017 Clinical Trials

43. A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

based therapy (e.g., intense pulsed light [IPL], photo-dynamic therapy [PDT]; 180 days Liquid nitrogen, electrodesiccation, curettage, imiquimod, 5-flurouracil (5FU), or ingenol mebutate; 60 days Retinoids; 28 days Microdermabrasion or superficial chemical peels; 14 days Corticosteroids or antibiotics; 14 days. Subject currently has or has had any of the following within the specified period prior to Visit 1 on or in a proximity to any Target Lesion that, in the investigator's opinion, interferes

2017 Clinical Trials

44. Chemical Peel

, Chemexfoliation II. Mechanism Chemical exfoliation of superficial skin layers using acids or enzymes (e.g. hydroxy acids) III. Indications (same indications as for Microdermabrasion) Benign epidermal pigmentation Rough skin Superficial acne scars IV. Dosing Course of 6 treatments every 4 weeks with maintenance treatments every 1-3 months V. Preparations Alpha hydroxy acids Lactid acid Beta hydroxy acids Salicylic acid VI. Efficacy Results are temporary VII. Advantages Inexpensive VIII. Disadvantages Difficult

2018 FP Notebook

45. Hand Rejuvenation: A Comprehensive Review of Fat Grafting. (Abstract)

such as microdermabrasion, peeling agents, and dermal fillers. This article details the surgical technique and relevant anatomy necessary for successful hand rejuvenation. Future advancements may rely on further study into adipose-derived stem cells. Copyright © 2016 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

2016 Journal of Hand Surgery - American

46. Noninvasive Facial Rejuvenation. Part 3: Physician-Directed—Lasers, Chemical Peels, and Other Noninvasive Modalities Full Text available with Trip Pro

youthful skin and rejuvenate damaged skin. Physicians may recommend and often prescribe certain products, but patients are in control with this type of facial rejuvenation. On the other hand, physician-directed facial rejuvenation entails modalities that require direct physician involvement, such as neuromodulators, filler injections, laser resurfacing, microdermabrasion, and chemical peels. With the successful integration of each of these modalities, a complete facial regimen can be established

2016 Seminars in plastic surgery

47. Noninvasive Facial Rejuvenation. Part 1: Patient-Directed Full Text available with Trip Pro

recommend and often prescribe certain products, but the patients are in control of this type of facial rejuvenation. On the other hand, physician-directed facial rejuvenation entails modalities that require direct physician involvement, such as neuromodulators, filler injections, laser resurfacing, microdermabrasion, and chemical peels. With the successful integration of each of these modalities, a complete facial regimen can be established and patient satisfaction can be maximized. This article

2016 Seminars in plastic surgery

48. Noninvasive Facial Rejuvenation. Part 2: Physician-Directed—Neuromodulators and Fillers Full Text available with Trip Pro

as rejuvenate damaged skin. Physicians may recommend and often prescribe certain products, but patients are in control with this type of facial rejuvenation. On the other hand, physician-directed facial rejuvenation entails modalities that require direct physician involvement, such as neuromodulators, filler injections, laser resurfacing, microdermabrasion, and chemical peels. With the successful integration of each of these modalities, a complete facial regimen can be established and patient satisfaction

2016 Seminars in plastic surgery

49. A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

within 6 months of baseline Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the 8 weeks of the first dose or during the study A positive urine drug screen for drugs of abuse, including alcohol or positive urine cotinine (≥300 ng/mL for cotinine) at the screening visit or at entry to the clinic (Note: urine cotinine required at screening visit only) Treatment with any investigational drug within 30 days or 5 half-lives (whichever is longer) prior to the beginning

2016 Clinical Trials

50. A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

) within 12 months prior to baseline and vitamin A supplements >10,000 units/day within 6 months prior to baseline Facial procedures (eg, microdermabrasion, chemical or laser peel) within 8 weeks prior to baseline Photodynamic therapy within 12 weeks prior to baseline Any other reason that would make the subject, in the opinion of the Investigator or Sponsor, unsuitable for the study Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you

2016 Clinical Trials

51. Retinol on Human Skin Aging in East Asian Descent

in the areas of skin biopsy that would obscure results of analysis topical creams or treatment to arms 2 weeks prior to study baseline visit individuals with known hypersensitivity to retinoid class of agents (older group only) prior anti-aging treatments to arms including retinol, microdermabrasion within 2 weeks of baseline visit prior laser therapy or surgical procedure to arms prior radiation or other trauma (extensive burns or abrasions) to arm skin hormone-based therapy within 4 weeks of enrollment

2016 Clinical Trials

52. Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines

than study treatment). Known immunization or hypersensitivity to any botulinum toxin serotype. Known allergy or sensitivity to any of the components of the study treatments, or any materials used in the study procedures. Any of the following procedures or treatments occurring within the specified period prior to screening: 3 months: Non-ablative resurfacing laser or light treatment, microdermabrasion, or superficial peels. 6 months: Any facial cosmetic procedure with medium depth to deep facial

2016 Clinical Trials

53. Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

to stop all facial treatments during the course of the study including botulinum toxin, injectable fillers, microdermabrasion, Intense pulsed light (IPL), peels, facials, waxing, laser treatments and tightening treatments. Threading is allowed but not facial laser hair removal. Willingness to cooperate follow all study requirements for the duration of the study and to report any changes in health status or medications, adverse event symptoms, or reactions immediately. Willingness to not begin using (...) (HRT) or hormones for birth control less than 3 months prior to study entry or who plan on starting, stopping, or changing doses of HRT or hormones for birth control during the study. Individuals who used any of the following medications or had any of the listed procedures within the listed time frame prior to the study start date: Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, or Differin® within 3 months Had a light-depth chemical peel or microdermabrasion within 1 month Had a medium-depth

2016 Clinical Trials

54. Subject Reported Outcomes With Use of Adapalene 0.3%

of the following topical treatments on the treated area: Corticosteroids, antibiotics, benzoyl peroxide, azelaic acid, dapsone, hydroxyacids, Zinc containing treatments, antiseptics, other anti-inflammatory products or other acne treatments (2 weeks); Retinoids (4 weeks); Cosmetic/aesthetic procedures on the face (1 week); Wax epilation (2 weeks); Photodynamic therapy (6 weeks); Laser therapy, microdermabrasion, deep chemical peel, plastic surgery for acne (3 months). Subjects having received at least one

2016 Clinical Trials

55. An Open-Label Safety Study of A-101 Solution

, electrodesiccation, curettage, imiquimod, 5-flurouracil, or ingenol mebutate; Retinoids; Microdermabrasion or superficial chemical peels; Glucocortico-steroids or antibiotics Subject currently has or has had any of the following within the specified period or in a proximity to any Target Lesion that, in the investigator's opinion, interferes with the study medication treatment or the study assessments: A cutaneous malignancy; A sunburn; currently A pre-malignancy (e.g., actinic keratosis); currently Body art

2016 Clinical Trials

56. A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis

within the specified period or in a proximity to any Target Lesion, that in the investigator's opinion interferes with the study medication treatment or the study assessments: LASER, light or other energy based therapy (e.g., intense pulsed light, photo-dynamic therapy; Liquid nitrogen, electrodesiccation, curettage, imiquimod, 5-flurouracil, or ingenol mebutate; Retinoids; Microdermabrasion or superficial chemical peels; Glucocortico-steroids or antibiotics 6. Subject currently has or has had any

2016 Clinical Trials

57. A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

; Microdermabrasion or superficial chemical peels; Glucocortico-steroids or antibiotics Subject currently has or has had any of the following within the specified period or in a proximity to any Target Lesion that, in the investigator's opinion, interferes with the study medication treatment or the study assessments: A cutaneous malignancy; A sunburn; currently A pre-malignancy (e.g., actinic keratosis); currently Body art (e.g., tattoos, piercing, etc.); currently Excessive tan; currently Subject has a history

2016 Clinical Trials

58. TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

(includes derivatives thereof) on the chest within 14 days prior to or during the study period, other than the study products A subject receiving any investigational drug and/or has had a microdermabrasion (light or medium skin peel) treatment on their chest within 30 days prior to or during the study period A subject using any topical tretinoin product or derivative on their chest within 12 weeks prior to or during the study period A subject receiving a chemical peel, any systemic steroids, a non

2016 Clinical Trials

59. A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

, lactating, nursing or planning to become pregnant Tattoo in the treatment area Active skin disease, excessive scarring or excess facial hair in the treatment area Certain current or recent acne treatments Recent light treatments including Intense Pulsed Light or other lasers, microdermabrasion or chemical peels in the treatment area Contraindicated for laser treatment, or is unable or unwilling to avoid excessive sun exposure or tanning bed use Known allergy to gold Contacts and Locations Go

2016 Clinical Trials

60. Simulines Non-Inferiority Pivotal Study

the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within two weeks prior to study participation or during the study. Marked asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, or thick sebaceous skin in the area(s) to be treated. History of chronic drug or alcohol abuse. Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study device

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>